DIAMONDS is the culmination of over a decade of collaborations with partners across the globe and nearly €60 million in EU-funding, building upon the research from three past projects, ILULU, EUCLIDS, and PERFORM. Together, they have paved the way for DIAMONDS’ work in developing a molecular test for the rapid diagnosis of serious infectious and inflammatory diseases using personalised gene signatures.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 848196